Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Dietary micronutrient intake and atherosclerosis in systemic lupus erythematosus.

Lourdudoss C, Elkan AC, Hafström I, Jogestrand T, Gustafsson T, van Vollenhoven R, Frostegård J.

Lupus. 2016 Jun 22. pii: 0961203316655211. [Epub ahead of print]

PMID:
27334936
2.

IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.

Rahman M, Sing S, Golabkesh Z, Fiskesund R, Gustafsson T, Jogestrand T, Frostegård AG, Hafström I, Liu A, Frostegård J.

Clin Immunol. 2016 May;166-167:27-37. doi: 10.1016/j.clim.2016.04.007. Epub 2016 Apr 19.

PMID:
27102765
3.

The association between diet and glucocorticoid treatment in patients with SLE.

Lourdudoss C, Hafström I, Frostegård J, van Vollenhoven R.

Lupus Sci Med. 2016 Jan 27;3(1):e000135. doi: 10.1136/lupus-2015-000135. eCollection 2016.

4.

Coenzyme Q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus.

Forsberg E, Xu C, Grünler J, Frostegård J, Tekle M, Brismar K, Kärvestedt L.

J Diabetes Complications. 2015 Nov-Dec;29(8):1152-8. doi: 10.1016/j.jdiacomp.2015.08.006. Epub 2015 Aug 13.

PMID:
26395643
5.

Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.

Ajeganova S, Gustafsson T, Jogestrand T, Frostegård J, Hafström I.

Arthritis Res Ther. 2015 Mar 25;17:84. doi: 10.1186/s13075-015-0595-4.

6.

Prediction and management of cardiovascular outcomes in systemic lupus erythematosus.

Frostegård J.

Expert Rev Clin Immunol. 2015 Feb;11(2):247-53. doi: 10.1586/1744666X.2015.993970. Epub 2014 Dec 17. Review.

PMID:
25517760
7.

Antibodies against native and oxidized cardiolipin and phosphatidylserine and phosphorylcholine in atherosclerosis development.

Frostegård AG, Su J, Hua X, Vikström M, de Faire U, Frostegård J.

PLoS One. 2014 Dec 4;9(12):e111764. doi: 10.1371/journal.pone.0111764. eCollection 2014.

8.

Induction of dendritic cell-mediated T-cell activation by modified but not native low-density lipoprotein in humans and inhibition by annexin a5: involvement of heat shock proteins.

Liu A, Ming JY, Fiskesund R, Ninio E, Karabina SA, Bergmark C, Frostegård AG, Frostegård J.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):197-205. doi: 10.1161/ATVBAHA.114.304342. Epub 2014 Nov 13.

9.

IgM-antibodies against phosphorylcholine in mothers and normal or low birth weight term newborn infants.

Frostegård AG, Sjöberg BG, Frostegård J, Norman M.

PLoS One. 2014 Sep 30;9(9):e106584. doi: 10.1371/journal.pone.0106584. eCollection 2014.

10.

Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men.

Gigante B, Leander K, Vikström M, Baldassarre D, Veglia F, Strawbridge RJ, McLeod O, Gertow K, Sennblad B, Shah S, Zabaneh D, Humphries SE, Kauhanen J, Rauramaa R, Smit AJ, Mannarino E, Giral P, Tremoli E, Hamsten A, Frostegård J, de Faire U; IMPROVE Study Group.

Atherosclerosis. 2014 Oct;236(2):394-9. doi: 10.1016/j.atherosclerosis.2014.07.030. Epub 2014 Aug 5.

PMID:
25150937
11.

Oxidized but not native cardiolipin has pro-inflammatory effects, which are inhibited by Annexin A5.

Wan M, Hua X, Su J, Thiagarajan D, Frostegård AG, Haeggström JZ, Frostegård J.

Atherosclerosis. 2014 Aug;235(2):592-8. doi: 10.1016/j.atherosclerosis.2014.05.913. Epub 2014 Jun 7.

PMID:
24956533
12.

Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult.

Fiskesund R, Steen J, Amara K, Murray F, Szwajda A, Liu A, Douagi I, Malmström V, Frostegård J.

J Immunol. 2014 May 15;192(10):4551-9. doi: 10.4049/jimmunol.1303035. Epub 2014 Apr 11.

13.

PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6.

Oparina NY, Delgado-Vega AM, Martinez-Bueno M, Magro-Checa C, Fernández C, Castro RO, Pons-Estel BA, D'Alfonso S, Sebastiani GD, Witte T, Lauwerys BR, Endreffy E, Kovács L, Escudero A, López-Pedrera C, Vasconcelos C, da Silva BM, Frostegård J, Truedsson L, Martin J, Raya E, Ortego-Centeno N, de Los Angeles Aguirre M, de Ramón Garrido E, Palma MJ, Alarcon-Riquelme ME, Kozyrev SV.

Ann Rheum Dis. 2015 Mar;74(3):e14. doi: 10.1136/annrheumdis-2013-204909. Epub 2014 Feb 17.

PMID:
24534757
14.
15.

Immune mechanisms in atherosclerosis, especially in diabetes type 2.

Frostegård J.

Front Endocrinol (Lausanne). 2013 Oct 29;4:162. doi: 10.3389/fendo.2013.00162. Review.

16.

Low levels of antibodies against oxidized but not nonoxidized cardiolipin and phosphatidylserine are associated with atherosclerotic plaques in systemic lupus erythematosus.

Su J, Frostegård AG, Hua X, Gustafsson T, Jogestrand T, Hafström I, Frostegård J.

J Rheumatol. 2013 Nov;40(11):1856-64. doi: 10.3899/jrheum.121173. Epub 2013 Sep 15.

PMID:
24037548
17.

Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain.

Waldheim E, Elkan AC, Pettersson S, van Vollenhoven R, Bergman S, Frostegård J, Welin Henriksson E.

Lupus. 2013 Oct;22(11):1118-27. doi: 10.1177/0961203313502109. Epub 2013 Aug 29.

PMID:
23989737
18.

Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.

Ajeganova S, Andersson ML, Frostegård J, Hafström I.

J Rheumatol. 2013 Dec;40(12):1958-66. doi: 10.3899/jrheum.130365. Epub 2013 Aug 15.

PMID:
23950188
19.

Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality.

Frostegård AG, Hua X, Su J, Carrero JJ, Heimbürger O, Bárány P, Stenvinkel P, Frostegård J.

Clin Exp Immunol. 2013 Dec;174(3):441-8. doi: 10.1111/cei.12181.

20.

Immunity, atherosclerosis and cardiovascular disease.

Frostegård J.

BMC Med. 2013 May 1;11:117. doi: 10.1186/1741-7015-11-117. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk